The Food and Drug Administration today proposed reclassifying surgical staplers for internal use as moderate-risk rather than low-risk medical devices. The change would allow the agency to require premarket review of the devices and establish special controls such as mandatory performance testing of the device’s features, usability and labeling. In addition, FDA announced draft guidance to help manufacturers ensure their labeling provides adequate information for use, and a May 30 advisory committee meeting to receive expert input on the proposed reclassification and guidance. The agency has received reports of more than 9,000 serious injuries and 366 patient deaths associated with the devices since 2011, and last month issued additional safety recommendations for health care providers using the devices.

Related News Articles

Headline
The Food and Drug Administration today reported 55 injuries and one death involving an infusion pump and vital signs monitoring system. Becton Dickinson…
Headline
The Food and Drug Administration Friday cleared for marketing in the U.S. the first fully disposable duodenoscope. The EXALT Model D Single-Use Duodenoscope is…
Headline
The Food and Drug Administration today announced a voluntary pilot program to expedite approvals of certain changes to ethylene oxide sterilization processes…
Headline
The Food and Drug Administration should study potential alternatives to ethylene oxide for sterilizing medical devices, but a solution could be at least a…
Headline
The Food and Drug Administration today alerted the public to growing concern about the potential for medical device shortages as facilities that sterilize…
Headline
The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk…